Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Share Pledge

Natco Pharma Share Pledge

Natco Pharma promoter V.C. Nannapaneni pledged 8,50,000 equity shares to Bajaj Financial Securities Limited. The pledge supports the promoter's subscription to the company's Rights Issue.

Source

BSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Natco Pharma Ltd: key numbers

Share price
₹788.75
Market cap
₹15,473 Cr
Revenue (annual)
₹4,078 Cr
Net profit (annual)
₹1,418 Cr
P/E (TTM)
13.5×Sector 37.9×
Promoter holding
46.22%-3.20% QoQ
FII holding
15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Natco Pharma Ltd

All →
14:19 IST NSE
Product Launch

Natco Pharma Product Launch

Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.

Other share pledge announcements

All →